The emergence of persistent ill-health in the aftermath of SARS-CoV-2 infection has
presented significant challenges to patients, healthcare workers and researchers. Termed …

An increase in the incidence of inflammatory arthritis after COVID-19 has been reported.
Since many diseases exhibit population-specific causal effect sizes, we aimed to evaluate …

Background Several autoimmune features occur during coronavirus disease 2019 (COVID‐
19), with possible implications for disease course, immunity, and autoimmune pathology. In …

During the COVID-19 pandemic, much of the media focus has been on adaptive immunity,
particularly antibody levels and memory T cells. However, immunologists have been striving …

The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Since the arrival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019, its characterization as a novel human pathogen, and the resulting …

Consecutive mRNA vaccinations against SARS-CoV-2 reinforced both innate and adaptive
immune responses. However, it remains unclear whether the enhanced innate immune …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Human infectious diseases are unique in that the discovery of their environmental trigger,
the microbe, was sufficient to drive the development of extraordinarily effective principles …

El SARS-CoV-2 es un virus ARN monocatenario de la familia de los coronavirus, causante
de la COVID-19 (Coronavirus Disease 2019). Este virus es responsable de la pandemia …